About 60 percent of all cancer patients in the United States receive radiation therapy as part of their treatment.

For decades, researchers have worked to create drugs that teach the immune system to kill cancer cells the way traditional ...

mRNAをベースとするがんワクチンが、膵臓がん患者を対象とした小規模治験で印象的な成果を上げ、手術後の再発リスクを低減する長期的な免疫反応を誘導（刺激）できる可能性を示唆している。 mRNAワクチン「autogene ...

Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra ...

As few as one in ten people survive pancreatic cancer five years after their diagnosis — making it the most difficult cancer to survive. The survival rate five years after diagnosis is 6-14%, but ...

Recent positive lab confirmation of Smart mRNA functionality is a tremendous milestone for the Company. This marks a ...

Clinical studies indicate that the mRNA vaccine may help treat pancreatic cancer, one of the deadliest cancers, reports ...

Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...

Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Cancer remains a leading cause of death globally but according to the World Health Organisation many cancers can be beaten if ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.